key: cord-0865517-qwh0al3v
authors: Teaima, Ahmed Abdelmoneim; Salem, Osama Maher; Teama, Mohammed Abd El Monem; Mansour, Ossama Ibrahim; Taha, Mohamed Shehata; Badr, Fatma Mohammed; Khater, Shaimaa Sayed; Abdou, Khaled; Mahmoud, Mohammad Salah
title: Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients()
date: 2021-09-30
journal: Am J Otolaryngol
DOI: 10.1016/j.amjoto.2021.103259
sha: 4f942bd11e31e9dd6ffe6414312946c1509ec4a9
doc_id: 865517
cord_uid: qwh0al3v

OBJECTIVE: This study aims to comprehensively evaluate olfactory and gustatory dysfunctions during the COVID-19 pandemic regarding onset, course, associated symptoms, prognosis and relation to patients' demographics, treatment received and other symptoms. PATIENTS& METHODS: This is a prospective study conducted on patients proven to be infected with COVID-19 and with olfactory/gustatory dysfunction symptoms. Detailed history was taken from each patient about the onset of this dysfunction, associated symptoms. Then follow-up survey was done after 6 months to evaluate the prognosis. RESULTS: 1031 patients were included in the study, aged 18 to 69 years old, with 31.8% were male. Olfactory/gustatory dysfunctions occurred after other COVID-19 symptoms in 43.5% of cases, occurred suddenly in 80.4% and gradually in 19.6%. These dysfunctions were anosmia & ageusia in 50.2%, hyposmia & hypogeusia in 23.3%, anosmia alone in 17.7%, phantosmia in 18%, Parosmia in 28.4%. In terms of recovery 6-month follow up, 680 patients (66%) recovered completely, 22.1% recovered partially while 11.9% did not recover. Most improvement occurred in the first two weeks. Headache, malaise, nasal obstruction and rhinorrhea were the commonest COVID-19 symptoms associated. CONCLUSION: Most recovery of olfactory/gustatory dysfunction in COVID-19 infection occurs at the first two weeks and is unrelated to patient demographics, treatment or olfactory training. Parosmia is an independent predictor for complete recovery, while phantosmia is significantly associated with lower probability of complete recovery.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) began and spread in China by the end of 2019 after that received worldwide attention. By the end of January 2020, WHO officially declared Coronavirus disease 2019 (COVID-19) epidemic as a public health emergency of international concern and as a pandemic in March 2020. Since then, COVID-19 hits every corner of the world (1) . Anosmia and taste disorders are considered main symptoms associated with the COVID-19 infection and as potential screening symptoms for suspecting and testing for COVID-19 (2, 3) . Nasal respiratory and olfactory cells express Angiotensin Converting Enzyme 2 proteins which are used by the COVID-19 virus to infect cells. Also, some strains of coronavirus could invade the olfactory bulb symptoms and prognosis of olfactory and gustatory symptoms. Our study aims to document all these missing data comprehensively using more than one thousand patient data.

This is a prospective study for olfactory and gustatory dysfunctions in patients evaluated at tertiary referral center and confirmed to be positive by PCR of nasopharyngeal swab from 1 st August 2020 to 31 st October 2020. Inclusion criteria included patients with mild to moderate adult COVID-19 patients who presented with olfactory and/or gustatory dysfunctions. All patients with history of nasal or oral surgery or trauma, chronic rhinosinusitis, previous history (before the pandemic) of olfactory or gustatory functions were excluded.

Detailed history was taken from each patient by physicians or nurses completing sheets to document the onset of olfactory and gustatory dysfunction and associated symptoms. Then follow up survey was done after 6 months by phone call or physically to document the progression of olfactory and gustatory dysfunction and their prognosis. Data collection was conducted anonymously, and no reward was offered for completion. In terms of recovery of olfactory/ gustatory dysfunctions after 6-month follow up, 680 patients (66%) recovered completely, 22.1 % recovered partially while 11.9% J o u r n a l P r e -p r o o f did not recover. Most improvement occurred in the first two weeks (in 637 /908 patients (70.1%)). This agrees with Hopkins et al who stated a significant recovery rate in the first 2 weeks but then it became plateau (4).

Oscolo-Rizzo et al reported 69.5% complete recovery after 12 months, 21.9% partial recovery and 8.6% no improvement (7). Hopkins et al stated improvement rate was 79% while 17.3% had persistent anosmia after 4 weeks of follow up (4).

According to Lechien et al, over one third of the patients recovered from olfactory dysfunction in the first two weeks, 54.3% recovered after one month. 24.5% did not recove after two months. Recovery rate ranges from 75% to 85% in the first two months (8) patients. According to studies, this is due to differences in the expression of ACE2 between individuals. The more expression of these proteins is mostly associated with longer duration of smell changes and more injury to stem neuron cells in the olfactory bulb. (11,12) By analyzing every factor in the current study in terms of improvement of olfactory/ gustatory dysfunctions or complete recovery after adjustment for the effect of other factors, we found a statistically significant association between parosmia and partial or complete recovery. Also, parosmia was an independent J o u r n a l P r e -p r o o f predictor for complete recovery while phantosmia was significantly associated with lower probability of complete recovery.

Most recovery of olfactory/ gustatory dysfunction in COVID-19 infection occurs at the first two weeks and is unrelated to patient demographics, treatment or olfactory training. Parosmia is an independent predictor for complete recovery while phantosmia is significantly associated with lower probability of complete recovery. 

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study